Home NDC 58151-115 Dilantin-125
Product NDC 58151-115
11-digit product format 581510115
Labeler code 58151
Product ID 58151-115_f339f9e4-b289-4efe-82b9-46c57d1dc277
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Phenytoin
Dosage form SUSPENSION
Route ORAL
Labeler Viatris Specialty LLC
Application NDA008762
Marketing category NDA
Marketing start 2024-04-19
Substance PHENYTOIN
Active strength 125 mg/5mL
Pharmacologic classes Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N008762-001 DILANTIN-125 PHENYTOIN 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 N008762-002 DILANTIN-30 PHENYTOIN 30MG/5ML SUSPENSION / ORAL Approved before 1982
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N008762-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N008762-001 DILANTIN-125 125MG/5ML SUSPENSION / ORAL AB RLD, RS, Approved before 1982 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N008762-002 DILANTIN-30 30MG/5ML SUSPENSION / ORAL Approved before 1982 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Dilantin-125
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PHENYTOIN 125 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 6158TKW0C5 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1313112 Internal RxNorm lookup 1313884 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 58151-115-35 Dilantin-125 237 mL in 1 BOTTLE, PLASTIC SUSPENSION 237 1 58151-115-35 Dilantin-125 1 in 1 CARTON SUSPENSION 1 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 58151-115 DILANTIN-125 (PHENYTOIN) SUSPENSION [VIATRIS SPECIALTY LLC] 1 Current NDC, 2 package rows 20240420_f339f9e4-b289-4efe-82b9-46c57d1dc277.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 58151-115-35 58151011535 1 BOTTLE, PLASTIC in 1 CARTON (58151-115-35) / 237 mL in 1 BOTTLE, PLASTIC 2024-04-19 No No Current